ABSTRACT
Background: The use of embryo cryopreservation excludes the possible detrimental effects of ovarian stimulation on the endometrium, and higher reproductive outcomes following this policy have been reported. Moreover, gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone [GnRH] antagonist cycles as a substitute for standard human chorionic gonadotropin trigger, minimizes the risk of ovarian hyperstimulation syndrome [OHSS] in fresh as well as frozen embryo transfer cycles [FET]
Objective: To compare the reproductive outcomes and risk of OHSS in fresh vs frozen embryo transfer in high responder patients, undergoing in vitro fertilization triggered with a bolus of GnRH agonist
Materials and Methods: In this randomized, multi-centre study, 121 women undergoing FET and 119 women undergoing fresh ET were investigated as regards clinical pregnancy as the primary outcome and the chemical pregnancy, live birth, OHSS development, and perinatal data as secondary outcomes
Results: There were no significant differences between FET and fresh groups regarding chemical [46.4% vs. 40.2%, p=0.352], clinical [35.8% vs. 38.3%, p=0.699], and ongoing [30.3% vs. 32.7%, p=0.700] pregnancy rates, also live birth [30.3% vs. 29.9%, p=0.953], perinatal outcomes, and OHSS development [35.6% vs. 42.9%, p=0.337]. No woman developed severe OHSS and no one required admission to hospital
Conclusion: Our findings suggest that GnRHa trigger followed by fresh transfer with modified luteal phase support in terms of a small human chorionic gonadotropin bolus is a good strategy to secure good live birth rates and a low risk of clinically relevant OHSS development in in vitro fertilization patients at risk of OHSS
ABSTRACT
Background: Despite of higher pregnancy rate after frozen embryo transfer [FET] which is accepted by the majority of researches, the safety of this method and its effect on neonatal outcome is still under debate
Objective: The aim of this study was to evaluate pregnancy and neonatal outcome of FET compare to fresh cycles
Materials and Methods: In this study,1134 patients using fresh ET and 285 women underwent FET were investigated regarding live birth as primary outcome and gestational age, birth weight, gender, multiple status, ectopic pregnancy, still birth and pregnancy loss as secondary outcomes
Results: Our results showed that there is no difference between FET and fresh cycles regarding live birth [65.6% vs. 70.4% respectively]. Ectopic pregnancy, still birth and abortion were similar in both groups. The mean gestational age was significantly lower among singletons in FET group compared to fresh cycles [p=0.047]. Prematurity was significantly elevated among singleton infants in FET group [19.6%] in comparison to neonates born after fresh ET [12.8%] [p=0.037]
Conclusion: It seems that there is no major difference regarding perinatal outcome between fresh and frozen embryo transfer. Although, live birth is slightly increased in fresh cycles and prematurity was significantly increased among singleton infants in FET group
ABSTRACT
Background: repeated implantation failure [RIF] is defined as pregnancy failure after two to six times with at least ten high grade embryo transfer to uterus. A variety of causes have been anticipated for RIF, including anatomical, autoimmune, genetics, endocrine and thrombotic anomalies. Factors responsible for RIF have important implication regarding treatment however in many couples a perfect cause cannot be found
Cases: in these case series, we reported nine couples with RIF that after investigation no definitive etiology was found for RIF and empirical therapy by heparin, aspirin and or immunotherapy was not effective. In these cases we recommended transfer of embryos to surrogate uterus. Nine patients were studied and six of them developed a normal pregnancy [pregnancy rate=66.66%]
Conclusion: this study showed that surrogacy is a good option for treatment of RIF
ABSTRACT
Cryopreservation of embryos has been an usual component of clinic in assisted reproductive technology [ART] programs. Recently the dramatic increase in cryobiology activity in the clinical centers has enhanced methods of freezing and improved vitrification protocols are being developed. The aim of our study was to assess the effect of storage duration of frozen embryo on ART outcome. In this retrospective study the data of 651 frozen-thawed embryo transfer cycles were assessed over a 36-months period. Our patients were categorized according to storage time of freeze. Group I: less than 90 days, Group II: between 90-365 days. Group III: between 365-730 days. Group IV: between 730-1095 days. Group V: more than 1095 days. Clinical pregnancy and implantation rate were defined and statistical analysis was performed using Student t-test and Chi-square. According to our finding patient's mean age was 31.05 +/- 5.231 years [range, 18-53 years], and 1204 embryos were transferred . The mean storage duration was 296.72 +/- 301.82 days. The mean number of embryo transferred per cycle was similar between groups [p=0.224]. According to our analysis clinical pregnancy rate per embryo transfer cycle was similar between groups [p=0.563]. Our results showed that duration of storage had no negative effects on implantation of cryopreserved embryos. In our literature review we found a little article In this context. However our study showed duration of freezing don't have any negative effects on implantation and pregnancy outcome, but more studies are needed to evaluate long term effects of storage duration on babies were born by cryopreserved embryos